Sean Carter is a Charleston, South Carolina based male rheumatologist who is specialized in Rheumatology. Active license number of Sean Carter for Rheumatology is 86315 in South Carolina. Sean Carter treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Sean Carter speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Male
Practice Address:
171 Ashley Ave, Charleston, South Carolina, 29425-1900
Phone:
843-792-1414
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1255864146
NPI Enumeration Date:
06 Apr, 2017
NPI Last Update On:
28 Oct, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sean Carter are as mentioned below.
License Number
Specialization
State
Status
86315
Rheumatologist
South Carolina
Primary
37815
Internal Medicine
Alabama
Secondary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 751461, Charlotte, North Carolina
Zip:
28275-1461
Phone Number:
--
Fax Number:
--
Patients can reach Sean Carter at 171 Ashley Ave, Charleston, South Carolina or can call to book an appointment on 843-792-1414. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.